DHX57
gene geneOn this page
Also known as DDX57
Summary
DHX57 (DExH-box helicase 57, HGNC:20086) is a protein-coding gene on chromosome 2p22.1, encoding Putative ATP-dependent RNA helicase DHX57 (Q6P158). Probable ATP-binding RNA helicase.
Enables RNA binding activity.
Source: NCBI Gene 90957 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 257 total
- Dosage sensitivity (ClinGen): haploinsufficiency no evidence, triplosensitivity no evidence
- MANE Select transcript:
NM_198963
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20086 |
| Approved symbol | DHX57 |
| Name | DExH-box helicase 57 |
| Location | 2p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DDX57 |
| Ensembl gene | ENSG00000163214 |
| Ensembl biotype | protein_coding |
| Entrez | 90957 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 13 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000442331, ENST00000452978, ENST00000457308, ENST00000474104, ENST00000477981, ENST00000479345, ENST00000492042, ENST00000497514, ENST00000619207, ENST00000620517, ENST00000622155, ENST00000896807, ENST00000896808, ENST00000896809, ENST00000896810, ENST00000934861, ENST00000934862, ENST00000934863, ENST00000934864, ENST00000934865
RefSeq mRNA: 2 — MANE Select: NM_198963
NM_001329963, NM_198963
CCDS: CCDS1800
Canonical transcript exons
ENST00000457308 — 24 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003469500 | 38860999 | 38861837 |
| ENSE00003496885 | 38862145 | 38862333 |
| ENSE00003508799 | 38856340 | 38856461 |
| ENSE00003515801 | 38863361 | 38863519 |
| ENSE00003524091 | 38815521 | 38815655 |
| ENSE00003538343 | 38806559 | 38806693 |
| ENSE00003564915 | 38858661 | 38858836 |
| ENSE00003567885 | 38819049 | 38819144 |
| ENSE00003604085 | 38826516 | 38826689 |
| ENSE00003605523 | 38837831 | 38837947 |
| ENSE00003620409 | 38813821 | 38813895 |
| ENSE00003621008 | 38802715 | 38802915 |
| ENSE00003623204 | 38822993 | 38823269 |
| ENSE00003624899 | 38854054 | 38854178 |
| ENSE00003642471 | 38828340 | 38828436 |
| ENSE00003645477 | 38818877 | 38818960 |
| ENSE00003675573 | 38843005 | 38843210 |
| ENSE00003675906 | 38848269 | 38848402 |
| ENSE00003677960 | 38847019 | 38847073 |
| ENSE00003682247 | 38825847 | 38826047 |
| ENSE00003722429 | 38875787 | 38875934 |
| ENSE00003738961 | 38797729 | 38798442 |
| ENSE00003739735 | 38855057 | 38855252 |
| ENSE00003745132 | 38868182 | 38868411 |
Expression profiles
Bgee: expression breadth ubiquitous, 261 present calls, max score 97.98.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.3655 / max 215.3042, expressed in 1755 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 27894 | 11.3220 | 1755 |
| 27892 | 0.0318 | 4 |
| 27893 | 0.0059 | 3 |
| 27891 | 0.0058 | 2 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.98 | gold quality |
| buccal mucosa cell | CL:0002336 | 97.05 | gold quality |
| male germ cell | CL:0000015 | 93.80 | gold quality |
| right testis | UBERON:0004534 | 92.47 | gold quality |
| left testis | UBERON:0004533 | 92.39 | gold quality |
| cortical plate | UBERON:0005343 | 91.51 | gold quality |
| ventricular zone | UBERON:0003053 | 90.95 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.49 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 90.14 | gold quality |
| testis | UBERON:0000473 | 89.73 | gold quality |
| adenohypophysis | UBERON:0002196 | 87.33 | gold quality |
| monocyte | CL:0000576 | 87.24 | gold quality |
| mononuclear cell | CL:0000842 | 87.07 | gold quality |
| leukocyte | CL:0000738 | 86.99 | gold quality |
| tibia | UBERON:0000979 | 86.82 | gold quality |
| pituitary gland | UBERON:0000007 | 86.71 | gold quality |
| embryo | UBERON:0000922 | 86.54 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.33 | gold quality |
| visceral pleura | UBERON:0002401 | 85.31 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.19 | gold quality |
| right uterine tube | UBERON:0001302 | 84.99 | gold quality |
| sural nerve | UBERON:0015488 | 84.68 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 84.39 | gold quality |
| granulocyte | CL:0000094 | 84.32 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 84.15 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.13 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 84.12 | gold quality |
| right ovary | UBERON:0002118 | 84.11 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.97 | gold quality |
| adrenal cortex | UBERON:0001235 | 83.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.05 |
Regulation
Is transcription factor: no
Functional genomics
ClinGen dosage: haploinsufficiency 0 (no evidence), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dhx57 | ENSDARG00000057660 |
| mus_musculus | Dhx57 | ENSMUSG00000035051 |
| rattus_norvegicus | Dhx57 | ENSRNOG00000054272 |
| drosophila_melanogaster | CG1582 | FBGN0030246 |
Paralogs (18): DHX33 (ENSG00000005100), YTHDC2 (ENSG00000047188), DHX29 (ENSG00000067248), DHX8 (ENSG00000067596), DHX32 (ENSG00000089876), DHX35 (ENSG00000101452), DHX40 (ENSG00000108406), DHX15 (ENSG00000109606), HELB (ENSG00000127311), DHX30 (ENSG00000132153), DHX34 (ENSG00000134815), DHX9 (ENSG00000135829), DHX38 (ENSG00000140829), DQX1 (ENSG00000144045), DHX37 (ENSG00000150990), TDRD9 (ENSG00000156414), DHX36 (ENSG00000174953), DHX16 (ENSG00000204560)
Protein
Protein identifiers
Putative ATP-dependent RNA helicase DHX57 — Q6P158 (reviewed: Q6P158)
Alternative names: DEAH box protein 57
All UniProt accessions (5): A0A087WW12, A0A087WZ11, Q6P158, H7BZ23, H7C109
UniProt curated annotations — full annotation on UniProt →
Function. Probable ATP-binding RNA helicase.
Similarity. Belongs to the DEAD box helicase family. DEAH subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P158-1 | 1 | yes |
| Q6P158-2 | 2 | |
| Q6P158-3 | 3 |
RefSeq proteins (2): NP_001316892, NP_945314* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000571 | Znf_CCCH | Domain |
| IPR001650 | Helicase_C-like | Domain |
| IPR002464 | DNA/RNA_helicase_DEAH_CS | Conserved_site |
| IPR006575 | RWD_dom | Domain |
| IPR007502 | Helicase-assoc_dom | Domain |
| IPR009060 | UBA-like_sf | Homologous_superfamily |
| IPR011545 | DEAD/DEAH_box_helicase_dom | Domain |
| IPR011709 | DEAD-box_helicase_OB_fold | Domain |
| IPR014001 | Helicase_ATP-bd | Domain |
| IPR015940 | UBA | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR036855 | Znf_CCCH_sf | Homologous_superfamily |
| IPR042615 | DHX57_UBA | Domain |
| IPR048333 | HA2_WH | Domain |
| IPR059023 | RNA_hel_CTD | Domain |
Pfam: PF00270, PF00271, PF00642, PF04408, PF05773, PF07717, PF21010, PF26026
Catalyzed reactions (Rhea), 1 shown:
- ATP + H2O = ADP + phosphate + H(+) (RHEA:13065)
UniProt features (29 total): modified residue 5, splice variant 5, compositionally biased region 4, domain 3, sequence variant 3, sequence conflict 2, region of interest 2, chain 1, binding site 1, zinc finger region 1, coiled-coil region 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P158-F1 | 76.68 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 567–574
Post-translational modifications (5): 127, 132, 475, 477, 480
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 125 (showing top):
CCAWYNNGAAR_UNKNOWN, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, CACCAGC_MIR138, ACTGCAG_MIR173P, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, CAGCAGG_MIR370, AAACCAC_MIR140, RFX1_02, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, CAGCCTC_MIR4855P, GGATCCG_MIR127, GOBP_POSITIVE_REGULATION_OF_TRANSLATION, PARENT_MTOR_SIGNALING_UP, GOBP_REGULATION_OF_TRANSLATION
GO Biological Process (1): positive regulation of translation (GO:0045727)
GO Molecular Function (12): RNA binding (GO:0003723), RNA helicase activity (GO:0003724), helicase activity (GO:0004386), ATP binding (GO:0005524), zinc ion binding (GO:0008270), ATP hydrolysis activity (GO:0016887), RNA polymerase binding (GO:0070063), nucleotide binding (GO:0000166), nucleic acid binding (GO:0003676), protein binding (GO:0005515), hydrolase activity (GO:0016787), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ATP-dependent activity | 2 |
| binding | 2 |
| translation | 1 |
| regulation of translation | 1 |
| positive regulation of gene expression | 1 |
| positive regulation of protein metabolic process | 1 |
| nucleic acid binding | 1 |
| helicase activity | 1 |
| ATP-dependent activity, acting on RNA | 1 |
| catalytic activity, acting on RNA | 1 |
| nucleic acid conformation isomerase activity | 1 |
| catalytic activity, acting on a nucleic acid | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| transition metal ion binding | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| enzyme binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
3000 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DHX57 | DDX54 | Q8TDD1 | 662 |
| DHX57 | DDX46 | Q7L014 | 576 |
| DHX57 | MLST8 | Q9BVC4 | 518 |
| DHX57 | KIF13A | Q9H1H9 | 500 |
| DHX57 | DHX58 | Q96C10 | 473 |
| DHX57 | FANCM | Q8IYD8 | 467 |
| DHX57 | DICER1 | Q9UPY3 | 464 |
| DHX57 | DDX19A | Q9NUU7 | 450 |
| DHX57 | ARHGEF33 | A8MVX0 | 447 |
| DHX57 | STXBP4 | Q6ZWJ1 | 443 |
| DHX57 | NHLRC1 | Q6VVB1 | 427 |
| DHX57 | DDX60 | Q8IY21 | 427 |
| DHX57 | DHX34 | Q14147 | 426 |
| DHX57 | DDX1 | Q92499 | 424 |
| DHX57 | SCGN | O76038 | 418 |
IntAct
274 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DHX57 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.720 |
| DHX57 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.720 |
| DHX57 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-7 | DHX57 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-8 | DHX57 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-9 | DHX57 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| NEUROG3 | GXYLT2 | psi-mi:“MI:0914”(association) | 0.640 |
| H1-1 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| NOL12 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| DHX57 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| DHX57 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| DHX57 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DHX57 | CBX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DHX57 | ZNF473 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DHX57 | KRTAP9-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP44 | DHX57 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF473 | DHX57 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (328): DHX57 (Two-hybrid), DHX57 (Two-hybrid), DHX57 (Two-hybrid), DHX57 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS), DHX57 (Affinity Capture-MS)
ESM2 similar proteins: A0A0P0WGX7, A2BGR3, A3KFM7, A3KMI0, A4IHD2, A4PBL4, A6QQR4, B0R061, D3Z9Z9, D3ZA12, E1B7X9, F4I2H2, F4I9Q5, F4J9M5, F4JTF6, F4K128, F8VPZ5, G5EDG2, O14139, O18017, O42861, P0CQ66, P0CQ67, P32657, P32849, P32863, P40352, P87114, Q03468, Q04692, Q0D622, Q0PCS3, Q0WVW7, Q2NKX8, Q5FWR0, Q60EX7, Q6P158, Q6PGC1, Q7F2E4, Q7Z478
Diamond homologs: A1Z9L3, A2A4P0, B3QAB0, B4JT42, B4PRJ9, B4RC48, B6IVG3, D4A2Z8, F4HYJ7, F4IE66, F4IJV4, F4ILR7, F4IM84, F4JMJ3, F4JRJ6, F4K2E9, F4KGU4, O17438, O22899, O35286, O42643, O42945, O43143, O45244, O46072, O51767, O60231, P0C7L7, P0CE10, P15938, P20095, P24384, P24785, P34305, P34498, P36009, P37024, P43329, P45018, P53131
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 162 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Eukaryotic Translation Initiation | 7 | 20.6× | 5e-07 |
| Cap-dependent Translation Initiation | 7 | 20.6× | 5e-07 |
| SARS-CoV-1 modulates host translation machinery | 7 | 20.6× | 5e-07 |
| Formation of the ternary complex, and subsequently, the 43S complex | 10 | 20.5× | 9e-10 |
| Formation of a pool of free 40S subunits | 18 | 19.2× | 1e-16 |
| Eukaryotic Translation Elongation | 7 | 18.6× | 1e-06 |
| SRP-dependent cotranslational protein targeting to membrane | 19 | 18.1× | 1e-16 |
| Peptide chain elongation | 15 | 18.1× | 1e-13 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| negative regulation of DNA recombination | 5 | 40.1× | 1e-05 |
| chromosome condensation | 6 | 36.1× | 2e-06 |
| cytoplasmic translation | 18 | 23.8× | 3e-17 |
| ribosomal small subunit biogenesis | 11 | 17.9× | 6e-09 |
| translational initiation | 6 | 15.4× | 2e-04 |
| translation | 17 | 12.5× | 1e-11 |
| rRNA processing | 11 | 11.1× | 9e-07 |
| regulation of alternative mRNA splicing, via spliceosome | 6 | 10.5× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
257 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 208 |
| Likely benign | 16 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4262 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:38802713:A:AG | donor_loss | 1.0000 |
| 2:38802772:T:A | donor_gain | 1.0000 |
| 2:38802911:CTCAC:C | acceptor_gain | 1.0000 |
| 2:38802915:CCTG:C | acceptor_loss | 1.0000 |
| 2:38806594:AT:A | donor_gain | 1.0000 |
| 2:38806626:G:C | donor_gain | 1.0000 |
| 2:38816093:A:AC | donor_gain | 1.0000 |
| 2:38816094:C:CC | donor_gain | 1.0000 |
| 2:38816097:AGG:A | donor_gain | 1.0000 |
| 2:38818959:CC:C | acceptor_gain | 1.0000 |
| 2:38818960:CC:C | acceptor_gain | 1.0000 |
| 2:38819045:TTA:T | donor_loss | 1.0000 |
| 2:38819046:TA:T | donor_loss | 1.0000 |
| 2:38819047:A:AC | donor_gain | 1.0000 |
| 2:38819047:AC:A | donor_gain | 1.0000 |
| 2:38819048:C:CT | donor_gain | 1.0000 |
| 2:38819048:CC:C | donor_gain | 1.0000 |
| 2:38819048:CCT:C | donor_gain | 1.0000 |
| 2:38819048:CCTT:C | donor_gain | 1.0000 |
| 2:38819048:CCTTA:C | donor_gain | 1.0000 |
| 2:38819140:GATAC:G | acceptor_gain | 1.0000 |
| 2:38819141:ATAC:A | acceptor_gain | 1.0000 |
| 2:38819142:TAC:T | acceptor_gain | 1.0000 |
| 2:38819143:AC:A | acceptor_gain | 1.0000 |
| 2:38819143:ACC:A | acceptor_loss | 1.0000 |
| 2:38819144:CC:C | acceptor_gain | 1.0000 |
| 2:38819144:CCTAA:C | acceptor_loss | 1.0000 |
| 2:38819145:C:CC | acceptor_gain | 1.0000 |
| 2:38819145:CTAAA:C | acceptor_loss | 1.0000 |
| 2:38819146:T:G | acceptor_loss | 1.0000 |
AlphaMissense
9068 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:38802853:G:C | F1293L | 1.000 |
| 2:38802853:G:T | F1293L | 1.000 |
| 2:38802855:A:G | F1293L | 1.000 |
| 2:38806582:G:C | H1265D | 1.000 |
| 2:38815603:A:G | F1175S | 1.000 |
| 2:38823078:C:T | G1069D | 1.000 |
| 2:38825978:C:A | R961S | 1.000 |
| 2:38825978:C:G | R961S | 1.000 |
| 2:38825979:C:A | R961M | 1.000 |
| 2:38825979:C:G | R961T | 1.000 |
| 2:38826582:G:T | A916D | 1.000 |
| 2:38826672:A:G | L886P | 1.000 |
| 2:38828379:A:G | L867P | 1.000 |
| 2:38828420:A:C | F853L | 1.000 |
| 2:38828420:A:T | F853L | 1.000 |
| 2:38828422:A:G | F853L | 1.000 |
| 2:38855085:C:T | G626E | 1.000 |
| 2:38855133:G:T | A610D | 1.000 |
| 2:38798396:A:G | L1355P | 0.999 |
| 2:38798399:A:G | L1354P | 0.999 |
| 2:38798420:A:G | L1347P | 0.999 |
| 2:38802890:A:G | L1281P | 0.999 |
| 2:38806573:A:G | S1268P | 0.999 |
| 2:38806580:G:C | H1265Q | 0.999 |
| 2:38806580:G:T | H1265Q | 0.999 |
| 2:38806581:T:C | H1265R | 0.999 |
| 2:38815602:A:C | F1175L | 0.999 |
| 2:38815602:A:T | F1175L | 0.999 |
| 2:38815604:A:G | F1175L | 0.999 |
| 2:38815621:A:G | L1169P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000008139 (2:38839024 C>T), RS1000053160 (2:38821631 T>C), RS1000085753 (2:38803460 C>G), RS1000120840 (2:38805087 C>T), RS1000124861 (2:38821384 G>A), RS1000152604 (2:38845061 G>A,T), RS1000161155 (2:38827372 G>A), RS1000189556 (2:38848018 G>A,C), RS1000257920 (2:38860154 G>A,C), RS1000281182 (2:38798393 T>C), RS1000350024 (2:38870149 T>C,G), RS1000359558 (2:38839197 T>C), RS1000399898 (2:38865315 G>A,C), RS1000414809 (2:38828732 A>T), RS1000435762 (2:38865064 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_614 | Obesity-related traits | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004697 | estradiol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases activity, increases abundance, increases expression | 3 |
| Valproic Acid | decreases expression, affects expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ivermectin | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.